RA
URGN icon

Rosalind Advisors’s UroGen Pharma URGN Stock Holding History

Rosalind Advisors’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$7.43M Sell
542,366
-407,634
-43% -$5.58M 3.52% 14
2025
Q1 		$10.5M Buy
950,000
+80,000
+9% +$885K 5.11% 7
2024
Q4 		$9.27M Buy
+870,000
New +$9.27M 4.74% 8